Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy

Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy

Abstract Novel approaches with checkpoint inhibitors in immunotherapy continue to be essential in the treatment of non-small cell lung cancer (NSCLC). However, the low rate of primary response and the development of acquired resistance during the immunotherapy limit their long-term effectiveness. Th...

Full description

Bibliographic Details
Main Authors: Lucas C. Adam, Junaid Raja, Johannes M. Ludwig, Adebowale Adeniran, Scott N. Gettinger, Hyun S. Kim
Format: Article
Language:English
Published: BMJ Publishing Group 2018-12-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
NSCLC
Acquired resistance
Immune checkpoint inhibitors
Cryoablation
Online Access:http://link.springer.com/article/10.1186/s40425-018-0468-x

Internet

http://link.springer.com/article/10.1186/s40425-018-0468-x

Similar Items